Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-07-15

Clinical Trial Update: Pharmacokinetics (PK) Study of Epinephrine Inhalation Aerosol in Healthy Volunteers [Phase 1, Phase 2]

View source ↗

Summary

A PK study of an epinephrine inhalation aerosol in healthy volunteers was completed, reporting pharmacokinetic data for potential asthma therapy applications.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Epinephrine inhalation aerosol (epinephrine)

Snippet

Sponsor: Amphastar Pharmaceuticals, Inc. | Conditions: Asthma | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2014-07-15